Indraprastha Medical Corporation
Indraprastha Medical Corporation Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Indraprastha Medical Corporation
Start SIPIndraprastha Medical Corporation Investment Rating
-
Master Rating:
-
Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,099.45 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 11% is healthy, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 13% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 5% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 274 | 278 | 284 | 263 | 216 |
| Operating Expenses Qtr Cr | 241 | 240 | 241 | 226 | 188 |
| Operating Profit Qtr Cr | 33 | 38 | 44 | 37 | 28 |
| Depreciation Qtr Cr | 10 | 10 | 10 | 10 | 9 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 7 | 9 | 9 | 7 | 5 |
| Net Profit Qtr Cr | 20 | 21 | 25 | 20 | 15 |
Indraprastha Medical Corporation Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹85.81
- 50 Day
- ₹84.18
- 100 Day
- ₹82.51
- 200 Day
- ₹79.09
- 20 Day
- ₹85.22
- 50 Day
- ₹83.12
- 100 Day
- ₹83.26
- 200 Day
- ₹78.59
Indraprastha Medical Corporation Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹90.27 |
| Second Resistance | ₹91.29 |
| Third Resistance | ₹92.67 |
| RSI | 66.55 |
| MFI | 73.13 |
| MACD Single Line | 0.87 |
| MACD | 1.39 |
| Support | |
|---|---|
| First Resistance | ₹87.87 |
| Second Resistance | ₹86.49 |
| Third Resistance | ₹85.47 |
Indraprastha Medical Corporation Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 67,344 | 6,734,400 | 100 |
| Week | 182,259 | 18,225,860 | 100 |
| 1 Month | 100,898 | 10,089,795 | 100 |
| 6 Month | 104,075 | 10,041,135 | 96.48 |
Indraprastha Medical Corporation Result Highlights
Indraprastha Medical Corporation Synopsis
NSE-Medical-Hospitals
Indraprastha Med belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 1098.67 Cr. and Equity Capital is Rs. 91.67 Cr. for the Year ended 31/03/2023. Indraprastha Medical Corporation Ltd. is a Public Limited Listed company incorporated on 16/03/1988 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1988PLC030958 and registration number is 030958.| Market Cap | 834 |
| Sales | 1,099 |
| Shares in Float | 4.49 |
| No of funds | 7 |
| Yield | 3.36 |
| Book Value | 2.15 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | |
| Alpha | 0.13 |
| Beta | 0.98 |
Indraprastha Medical Corporation
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 51% | 51% | 51% | 51% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.27% | 0.77% | 0.15% | 0.09% |
| Financial Institutions/ Banks | 0.02% | 0.02% | ||
| Individual Investors | 29.66% | 30.11% | 31.25% | 31.4% |
| Others | 19.07% | 18.12% | 17.58% | 17.49% |
Indraprastha Medical Corporation Management
| Name | Designation |
|---|---|
| Mr. Jasmine Shah | Chairman |
| Dr. Prathap C Reddy | Vice Chairman |
| Mr. P Shivakumar | Managing Director |
| Mr. Deepak Vaidya | Director |
| Mr. Satnam Arora | Director |
| Mr. S Regunathan | Director |
| Ms. Suneeta Reddy | Director |
| Mr. Vinayak Chatterjee | Director |
| Ms. Vineeta Rai | Director |
| Ms. Madhumita Ganguli | Director |
| Dr. Menaka Guruswami | Director |
| Ms. Sangita Reddy | Director |
| Dr. Arun Rai | Director |
| Prof. (Dr) Mahesh Verma | Director |
| Mr. Salil Singhal | Director |
| Mr. Udit Prakash Rai | Director |
| Mr. Vikram Bhat | Director |
Indraprastha Medical Corporation Forecast
Price Estimates
Indraprastha Medical Corporation Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-23 | Audited Results & Dividend | |
| 2023-02-08 | Quarterly Results | |
| 2022-11-04 | Quarterly Results | |
| 2022-08-08 | Quarterly Results | |
| 2022-02-08 | Quarterly Results |
Indraprastha Medical Corporation FAQs
What is Share Price of Indraprastha Medical Corporation ?
Indraprastha Medical Corporation share price is ₹91 As on 01 June, 2023 | 17:27
What is the Market Cap of Indraprastha Medical Corporation ?
The Market Cap of Indraprastha Medical Corporation is ₹834.2 Cr As on 01 June, 2023 | 17:27
What is the P/E ratio of Indraprastha Medical Corporation ?
The P/E ratio of Indraprastha Medical Corporation is 9.7 As on 01 June, 2023 | 17:27
What is the PB ratio of Indraprastha Medical Corporation ?
The PB ratio of Indraprastha Medical Corporation is 2.2 As on 01 June, 2023 | 17:27